The FDA has approved the investigational new drug application of AS1986NS for prostate cancer detection and treatment.

CERo Therapeutics (CERO) announces that the U.S. Food and Drug Administration has cleared the Company’s Investigational New Drug ...

Submission of New Drug Application for Paltusotine for the Treatment of AcromegalyCompleted Upsized Public Offering of $575M of Common Stock ...

Announced that it has submitted a Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) seeking ...

This drug is the world’s first-ever CRISPR/Cas13 RNA-editing therapy for clinical use in treating neovascular age-related macular degeneration (nAMD). The US FDA has cleared an investigational new ...

Through a collaboration with the National Institutes of Health, Trevena is also exploring TRV045 as a potential treatment for epilepsy. S1P receptors are located throughout the body, including the ...

and information on how to submit an investigational new drug (IND) application to administer an investigational product to humans. The staff of CAB and MATTB comprises consumer safety officers ...

Gilead Sciences, Inc. today announced the presentation of new research data from its innovative HIV treatment portfolio and pipeline, including a broad range of data on investigational and marketed ...

Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated Milestones Ovaprene® hormone-free monthly intravaginal contraceptive candidate - pivotal Phase 3 contra ...

Recent positive Type C meeting with the U.S. Food and Drug Administration (FDA) confirmed ELPIS II is pivotal and, if positive, acceptable for Biological License Application (BLA) submission for full ...

The quarter also saw strategic regulatory advancements. Five Investigational New Drug applications were cleared for IMVT-1402. The potential approval of VTAMA for atopic dermatitis by the FDA ...